|
市場調査レポート
商品コード
1719422
末梢神経障害治療の世界市場 2025～2029年Global Peripheral Neuropathy Treatment Market 2025-2029 |
||||||
|
|
|||||||
カスタマイズ可能
|
|||||||
価格
| 末梢神経障害治療の世界市場 2025～2029年 |
|
出版日: 2025年04月24日
発行: TechNavio
ページ情報: 英文 233 Pages
納期: 即納可能
 |
- 全表示
- 概要
- 図表
- 目次
概要
末梢神経障害治療市場は2024-2029年に4億8,160万米ドル、予測期間中のCAGRは4.5%で成長すると予測されます。
当レポートでは、末梢神経障害治療市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、末梢神経障害の有病率の増加、末梢神経障害に対する最近の医薬品承認、末梢神経障害に対する意識の高まりによって牽引されています。
| 市場範囲 | |
|---|---|
| 基準年 | 2025 |
| 終了年 | 2029 |
| 予測期間 | 2025-2029 |
| 成長モメンタム | 加速 |
| 前年比2025年 | 4.2% |
| CAGR | 4.5% |
| 増分額 | 4億8,160万米ドル |
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要企業の分析に加え、包括的な市場規模データ、地域分析によるセグメント、ベンダー情勢が含まれています。レポートには過去データと予測データがあります。
本調査では、今後数年間の末梢神経障害治療市場の成長を促進する主な要因の一つとして、強力な医薬品パイプラインを挙げています。また、末梢神経障害治療に関連する新しい製剤や研究開発の増加による技術進歩は、市場の大きな需要につながるでしょう。
目次
第1章 エグゼクティブサマリー
- 市場概要
第2章 Technavio分析
- 価格・ライフサイクル・顧客購入バスケット・採用率・購入基準の分析
- インプットの重要性と差別化の要因
- 混乱の要因
- 促進要因と課題の影響
第3章 市場情勢
- 市場エコシステム
- 市場の特徴
- バリューチェーン分析
第4章 市場規模
- 市場の定義
- 市場セグメント分析
- 市場規模 2024
- 市場の見通し 2024-2029
第5章 市場規模実績
- 末梢神経障害治療の世界市場 2019-2023
- タイプ別セグメント分析 2019-2023
- 療法別セグメント分析 2019-2023
- 診断方法別セグメント分析 2019-2023
- エンドユーザー別セグメント分析 2019-2023
- 地域別セグメント分析 2019-2023
- 国別セグメント分析 2019-2023
第6章 定性分析
- AIの影響：末梢神経障害治療の世界市場
第7章 ファイブフォース分析
- ファイブフォースの要約
- 買い手の交渉力
- 供給企業の交渉力
- 新規参入業者の脅威
- 代替品の脅威
- 競争の脅威
- 市況
第8章 市場セグメンテーション：タイプ別
- 市場セグメント
- 比較：タイプ別
- 糖尿病患者：市場規模と予測 2024-2029
- 化学療法：市場規模と予測 2024-2029
- その他：市場規模と予測 2024-2029
- 市場機会：タイプ別
第9章 市場セグメンテーション：療法別
- 市場セグメント
- 比較：療法別
- 薬理学的療法：市場規模と予測 2024-2029
- 非薬物療法：市場規模と予測 2024-2029
- 市場機会：療法別
第10章 市場セグメンテーション：診断方法別
- 市場セグメント
- 比較：診断方法別
- 血液検査：市場規模と予測 2024-2029
- 生検：市場規模と予測 2024-2029
- 画像診断：市場規模と予測 2024-2029
- 市場機会：診断方法別
第11章 市場セグメンテーション：エンドユーザー別
- 市場セグメント
- 比較：エンドユーザー別
- 病院と診療所：市場規模と予測 2024-2029
- 小売薬局：市場規模と予測 2024-2029
- オンライン薬局：市場規模と予測 2024-2029
- 市場機会：エンドユーザー別
第12章 顧客情勢
- 顧客情勢の概要
第13章 地域別情勢
- 地域別セグメンテーション
- 地域別比較
- 北米：市場規模と予測 2024-2029
- 欧州：市場規模と予測 2024-2029
- アジア：市場規模と予測 2024-2029
- 世界のその他の地域：市場規模と予測 2024-2029
- 米国：市場規模と予測 2024-2029
- ドイツ：市場規模と予測 2024-2029
- 中国：市場規模と予測 2024-2029
- 英国：市場規模と予測 2024-2029
- 日本：市場規模と予測 2024-2029
- カナダ：市場規模と予測 2024-2029
- ブラジル：市場規模と予測 2024-2029
- インド：市場規模と予測 2024-2029
- 韓国：市場規模と予測 2024-2029
- フランス：市場規模と予測 2024-2029
- 市場機会：地域情勢別
第14章 促進要因・課題・機会・抑制要因
- 市場促進要因
- 市場の課題
- 促進要因と課題の影響
- 市場の機会・抑制要因
第15章 競合情勢
- 概要
- 競合情勢
- 混乱の状況
- 業界のリスク
第16章 競合分析
- 企業プロファイル
- 企業ランキング指数
- 企業の市場ポジショニング
- Apotex Inc.
- ASSERTIO HOLDINGS INC.
- AstraZeneca Plc
- Cadila Pharmaceuticals Ltd.
- Cipla Inc.
- Daiichi Sankyo Co. Ltd.
- Dr Reddys Laboratories Ltd.
- Eli Lilly and Co.
- Endo International Plc
- Hikma Pharmaceuticals Plc
- Johnson and Johnson Services Inc.
- Lupin Ltd.
- Novartis AG
- Pfizer Inc.
- Viatris Inc.
第17章 付録
図表
Exhibits:
- Exhibits1: Executive Summary - Chart on Market Overview
- Exhibits2: Executive Summary - Data Table on Market Overview
- Exhibits3: Executive Summary - Chart on Global Market Characteristics
- Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
- Exhibits5: Executive Summary - Chart on Market Segmentation by Type
- Exhibits6: Executive Summary - Chart on Market Segmentation by Therapy
- Exhibits7: Executive Summary - Chart on Market Segmentation by Diagnostic Methods
- Exhibits8: Executive Summary - Chart on Market Segmentation by End-user
- Exhibits9: Executive Summary - Chart on Incremental Growth
- Exhibits10: Executive Summary - Data Table on Incremental Growth
- Exhibits11: Executive Summary - Chart on Company Market Positioning
- Exhibits12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Exhibits13: Overview on criticality of inputs and factors of differentiation
- Exhibits14: Overview on factors of disruption
- Exhibits15: Impact of drivers and challenges in 2024 and 2029
- Exhibits16: Parent Market
- Exhibits17: Data Table on - Parent Market
- Exhibits18: Market characteristics analysis
- Exhibits19: Value chain analysis
- Exhibits20: Offerings of companies included in the market definition
- Exhibits21: Market segments
- Exhibits22: Chart on Global - Market size and forecast 2024-2029 ($ million)
- Exhibits23: Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Exhibits24: Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Exhibits25: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
- Exhibits26: Historic Market Size - Data Table on Global Peripheral Neuropathy Treatment Market 2019 - 2023 ($ million)
- Exhibits27: Historic Market Size - Type Segment 2019 - 2023 ($ million)
- Exhibits28: Historic Market Size - Therapy Segment 2019 - 2023 ($ million)
- Exhibits29: Historic Market Size - Diagnostic Methods Segment 2019 - 2023 ($ million)
- Exhibits30: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
- Exhibits31: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- Exhibits32: Historic Market Size - Country Segment 2019 - 2023 ($ million)
- Exhibits33: Five forces analysis - Comparison between 2024 and 2029
- Exhibits34: Bargaining power of buyers - Impact of key factors 2024 and 2029
- Exhibits35: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- Exhibits36: Threat of new entrants - Impact of key factors in 2024 and 2029
- Exhibits37: Threat of substitutes - Impact of key factors in 2024 and 2029
- Exhibits38: Threat of rivalry - Impact of key factors in 2024 and 2029
- Exhibits39: Chart on Market condition - Five forces 2024 and 2029
- Exhibits40: Chart on Type - Market share 2024-2029 (%)
- Exhibits41: Data Table on Type - Market share 2024-2029 (%)
- Exhibits42: Chart on Comparison by Type
- Exhibits43: Data Table on Comparison by Type
- Exhibits44: Chart on Diabetic - Market size and forecast 2024-2029 ($ million)
- Exhibits45: Data Table on Diabetic - Market size and forecast 2024-2029 ($ million)
- Exhibits46: Chart on Diabetic - Year-over-year growth 2024-2029 (%)
- Exhibits47: Data Table on Diabetic - Year-over-year growth 2024-2029 (%)
- Exhibits48: Chart on Chemotherapy - Market size and forecast 2024-2029 ($ million)
- Exhibits49: Data Table on Chemotherapy - Market size and forecast 2024-2029 ($ million)
- Exhibits50: Chart on Chemotherapy - Year-over-year growth 2024-2029 (%)
- Exhibits51: Data Table on Chemotherapy - Year-over-year growth 2024-2029 (%)
- Exhibits52: Chart on Others - Market size and forecast 2024-2029 ($ million)
- Exhibits53: Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Exhibits54: Chart on Others - Year-over-year growth 2024-2029 (%)
- Exhibits55: Data Table on Others - Year-over-year growth 2024-2029 (%)
- Exhibits56: Market opportunity by Type ($ million)
- Exhibits57: Data Table on Market opportunity by Type ($ million)
- Exhibits58: Chart on Therapy - Market share 2024-2029 (%)
- Exhibits59: Data Table on Therapy - Market share 2024-2029 (%)
- Exhibits60: Chart on Comparison by Therapy
- Exhibits61: Data Table on Comparison by Therapy
- Exhibits62: Chart on Pharmacological therapies - Market size and forecast 2024-2029 ($ million)
- Exhibits63: Data Table on Pharmacological therapies - Market size and forecast 2024-2029 ($ million)
- Exhibits64: Chart on Pharmacological therapies - Year-over-year growth 2024-2029 (%)
- Exhibits65: Data Table on Pharmacological therapies - Year-over-year growth 2024-2029 (%)
- Exhibits66: Chart on Non pharmacological therapies - Market size and forecast 2024-2029 ($ million)
- Exhibits67: Data Table on Non pharmacological therapies - Market size and forecast 2024-2029 ($ million)
- Exhibits68: Chart on Non pharmacological therapies - Year-over-year growth 2024-2029 (%)
- Exhibits69: Data Table on Non pharmacological therapies - Year-over-year growth 2024-2029 (%)
- Exhibits70: Market opportunity by Therapy ($ million)
- Exhibits71: Data Table on Market opportunity by Therapy ($ million)
- Exhibits72: Chart on Diagnostic Methods - Market share 2024-2029 (%)
- Exhibits73: Data Table on Diagnostic Methods - Market share 2024-2029 (%)
- Exhibits74: Chart on Comparison by Diagnostic Methods
- Exhibits75: Data Table on Comparison by Diagnostic Methods
- Exhibits76: Chart on Blood test - Market size and forecast 2024-2029 ($ million)
- Exhibits77: Data Table on Blood test - Market size and forecast 2024-2029 ($ million)
- Exhibits78: Chart on Blood test - Year-over-year growth 2024-2029 (%)
- Exhibits79: Data Table on Blood test - Year-over-year growth 2024-2029 (%)
- Exhibits80: Chart on Biopsy - Market size and forecast 2024-2029 ($ million)
- Exhibits81: Data Table on Biopsy - Market size and forecast 2024-2029 ($ million)
- Exhibits82: Chart on Biopsy - Year-over-year growth 2024-2029 (%)
- Exhibits83: Data Table on Biopsy - Year-over-year growth 2024-2029 (%)
- Exhibits84: Chart on Imaging - Market size and forecast 2024-2029 ($ million)
- Exhibits85: Data Table on Imaging - Market size and forecast 2024-2029 ($ million)
- Exhibits86: Chart on Imaging - Year-over-year growth 2024-2029 (%)
- Exhibits87: Data Table on Imaging - Year-over-year growth 2024-2029 (%)
- Exhibits88: Market opportunity by Diagnostic Methods ($ million)
- Exhibits89: Data Table on Market opportunity by Diagnostic Methods ($ million)
- Exhibits90: Chart on End-user - Market share 2024-2029 (%)
- Exhibits91: Data Table on End-user - Market share 2024-2029 (%)
- Exhibits92: Chart on Comparison by End-user
- Exhibits93: Data Table on Comparison by End-user
- Exhibits94: Chart on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
- Exhibits95: Data Table on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
- Exhibits96: Chart on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
- Exhibits97: Data Table on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
- Exhibits98: Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
- Exhibits99: Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
- Exhibits100: Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
- Exhibits101: Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
- Exhibits102: Chart on Online pharmacy - Market size and forecast 2024-2029 ($ million)
- Exhibits103: Data Table on Online pharmacy - Market size and forecast 2024-2029 ($ million)
- Exhibits104: Chart on Online pharmacy - Year-over-year growth 2024-2029 (%)
- Exhibits105: Data Table on Online pharmacy - Year-over-year growth 2024-2029 (%)
- Exhibits106: Market opportunity by End-user ($ million)
- Exhibits107: Data Table on Market opportunity by End-user ($ million)
- Exhibits108: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Exhibits109: Chart on Market share By Geographical Landscape 2024-2029 (%)
- Exhibits110: Data Table on Market share By Geographical Landscape 2024-2029 (%)
- Exhibits111: Chart on Geographic comparison
- Exhibits112: Data Table on Geographic comparison
- Exhibits113: Chart on North America - Market size and forecast 2024-2029 ($ million)
- Exhibits114: Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Exhibits115: Chart on North America - Year-over-year growth 2024-2029 (%)
- Exhibits116: Data Table on North America - Year-over-year growth 2024-2029 (%)
- Exhibits117: Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Exhibits118: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Exhibits119: Chart on Europe - Year-over-year growth 2024-2029 (%)
- Exhibits120: Data Table on Europe - Year-over-year growth 2024-2029 (%)
- Exhibits121: Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Exhibits122: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Exhibits123: Chart on Asia - Year-over-year growth 2024-2029 (%)
- Exhibits124: Data Table on Asia - Year-over-year growth 2024-2029 (%)
- Exhibits125: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Exhibits126: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Exhibits127: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Exhibits128: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Exhibits129: Chart on US - Market size and forecast 2024-2029 ($ million)
- Exhibits130: Data Table on US - Market size and forecast 2024-2029 ($ million)
- Exhibits131: Chart on US - Year-over-year growth 2024-2029 (%)
- Exhibits132: Data Table on US - Year-over-year growth 2024-2029 (%)
- Exhibits133: Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Exhibits134: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Exhibits135: Chart on Germany - Year-over-year growth 2024-2029 (%)
- Exhibits136: Data Table on Germany - Year-over-year growth 2024-2029 (%)
- Exhibits137: Chart on China - Market size and forecast 2024-2029 ($ million)
- Exhibits138: Data Table on China - Market size and forecast 2024-2029 ($ million)
- Exhibits139: Chart on China - Year-over-year growth 2024-2029 (%)
- Exhibits140: Data Table on China - Year-over-year growth 2024-2029 (%)
- Exhibits141: Chart on UK - Market size and forecast 2024-2029 ($ million)
- Exhibits142: Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Exhibits143: Chart on UK - Year-over-year growth 2024-2029 (%)
- Exhibits144: Data Table on UK - Year-over-year growth 2024-2029 (%)
- Exhibits145: Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Exhibits146: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Exhibits147: Chart on Japan - Year-over-year growth 2024-2029 (%)
- Exhibits148: Data Table on Japan - Year-over-year growth 2024-2029 (%)
- Exhibits149: Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Exhibits150: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Exhibits151: Chart on Canada - Year-over-year growth 2024-2029 (%)
- Exhibits152: Data Table on Canada - Year-over-year growth 2024-2029 (%)
- Exhibits153: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Exhibits154: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Exhibits155: Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Exhibits156: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- Exhibits157: Chart on India - Market size and forecast 2024-2029 ($ million)
- Exhibits158: Data Table on India - Market size and forecast 2024-2029 ($ million)
- Exhibits159: Chart on India - Year-over-year growth 2024-2029 (%)
- Exhibits160: Data Table on India - Year-over-year growth 2024-2029 (%)
- Exhibits161: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Exhibits162: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Exhibits163: Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Exhibits164: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- Exhibits165: Chart on France - Market size and forecast 2024-2029 ($ million)
- Exhibits166: Data Table on France - Market size and forecast 2024-2029 ($ million)
- Exhibits167: Chart on France - Year-over-year growth 2024-2029 (%)
- Exhibits168: Data Table on France - Year-over-year growth 2024-2029 (%)
- Exhibits169: Market opportunity By Geographical Landscape ($ million)
- Exhibits170: Data Tables on Market opportunity By Geographical Landscape ($ million)
- Exhibits171: Impact of drivers and challenges in 2024 and 2029
- Exhibits172: Overview on criticality of inputs and factors of differentiation
- Exhibits173: Overview on factors of disruption
- Exhibits174: Impact of key risks on business
- Exhibits175: Companies covered
- Exhibits176: Company ranking index
- Exhibits177: Matrix on companies position and classification
- Exhibits178: Apotex Inc. - Overview
- Exhibits179: Apotex Inc. - Product / Service
- Exhibits180: Apotex Inc. - Key news
- Exhibits181: Apotex Inc. - Key offerings
- Exhibits182: SWOT
- Exhibits183: ASSERTIO HOLDINGS INC. - Overview
- Exhibits184: ASSERTIO HOLDINGS INC. - Product / Service
- Exhibits185: ASSERTIO HOLDINGS INC. - Key offerings
- Exhibits186: SWOT
- Exhibits187: AstraZeneca Plc - Overview
- Exhibits188: AstraZeneca Plc - Product / Service
- Exhibits189: AstraZeneca Plc - Key news
- Exhibits190: AstraZeneca Plc - Key offerings
- Exhibits191: SWOT
- Exhibits192: Cadila Pharmaceuticals Ltd. - Overview
- Exhibits193: Cadila Pharmaceuticals Ltd. - Product / Service
- Exhibits194: Cadila Pharmaceuticals Ltd. - Key offerings
- Exhibits195: SWOT
- Exhibits196: Cipla Inc. - Overview
- Exhibits197: Cipla Inc. - Business segments
- Exhibits198: Cipla Inc. - Key news
- Exhibits199: Cipla Inc. - Key offerings
- Exhibits200: Cipla Inc. - Segment focus
- Exhibits201: SWOT
- Exhibits202: Daiichi Sankyo Co. Ltd. - Overview
- Exhibits203: Daiichi Sankyo Co. Ltd. - Product / Service
- Exhibits204: Daiichi Sankyo Co. Ltd. - Key offerings
- Exhibits205: SWOT
- Exhibits206: Dr Reddys Laboratories Ltd. - Overview
- Exhibits207: Dr Reddys Laboratories Ltd. - Business segments
- Exhibits208: Dr Reddys Laboratories Ltd. - Key news
- Exhibits209: Dr Reddys Laboratories Ltd. - Key offerings
- Exhibits210: Dr Reddys Laboratories Ltd. - Segment focus
- Exhibits211: SWOT
- Exhibits212: Eli Lilly and Co. - Overview
- Exhibits213: Eli Lilly and Co. - Product / Service
- Exhibits214: Eli Lilly and Co. - Key offerings
- Exhibits215: SWOT
- Exhibits216: Endo International Plc - Overview
- Exhibits217: Endo International Plc - Business segments
- Exhibits218: Endo International Plc - Key news
- Exhibits219: Endo International Plc - Key offerings
- Exhibits220: Endo International Plc - Segment focus
- Exhibits221: SWOT
- Exhibits222: Hikma Pharmaceuticals Plc - Overview
- Exhibits223: Hikma Pharmaceuticals Plc - Business segments
- Exhibits224: Hikma Pharmaceuticals Plc - Key news
- Exhibits225: Hikma Pharmaceuticals Plc - Key offerings
- Exhibits226: Hikma Pharmaceuticals Plc - Segment focus
- Exhibits227: SWOT
- Exhibits228: Johnson and Johnson Services Inc. - Overview
- Exhibits229: Johnson and Johnson Services Inc. - Business segments
- Exhibits230: Johnson and Johnson Services Inc. - Key news
- Exhibits231: Johnson and Johnson Services Inc. - Key offerings
- Exhibits232: Johnson and Johnson Services Inc. - Segment focus
- Exhibits233: SWOT
- Exhibits234: Lupin Ltd. - Overview
- Exhibits235: Lupin Ltd. - Business segments
- Exhibits236: Lupin Ltd. - Key news
- Exhibits237: Lupin Ltd. - Key offerings
- Exhibits238: Lupin Ltd. - Segment focus
- Exhibits239: SWOT
- Exhibits240: Novartis AG - Overview
- Exhibits241: Novartis AG - Business segments
- Exhibits242: Novartis AG - Key news
- Exhibits243: Novartis AG - Key offerings
- Exhibits244: Novartis AG - Segment focus
- Exhibits245: SWOT
- Exhibits246: Pfizer Inc. - Overview
- Exhibits247: Pfizer Inc. - Product / Service
- Exhibits248: Pfizer Inc. - Key news
- Exhibits249: Pfizer Inc. - Key offerings
- Exhibits250: SWOT
- Exhibits251: Viatris Inc. - Overview
- Exhibits252: Viatris Inc. - Business segments
- Exhibits253: Viatris Inc. - Key news
- Exhibits254: Viatris Inc. - Key offerings
- Exhibits255: Viatris Inc. - Segment focus
- Exhibits256: SWOT
- Exhibits257: Inclusions checklist
- Exhibits258: Exclusions checklist
- Exhibits259: Currency conversion rates for US$
- Exhibits260: Research methodology
- Exhibits261: Information sources
- Exhibits262: Data validation
- Exhibits263: Validation techniques employed for market sizing
- Exhibits264: Data synthesis
- Exhibits265: 360 degree market analysis
- Exhibits266: List of abbreviations
目次
Product Code: IRTNTR45413
The peripheral neuropathy treatment market is forecasted to grow by USD 481.6 mn during 2024-2029, accelerating at a CAGR of 4.5% during the forecast period. The report on the peripheral neuropathy treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of peripheral neuropathy, recent drug approvals for peripheral neuropathy, and rising awareness of peripheral neuropathy.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2029 |
| Series Year | 2025-2029 |
| Growth Momentum | Accelerate |
| YOY 2025 | 4.2% |
| CAGR | 4.5% |
| Incremental Value | $481.6 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's peripheral neuropathy treatment market is segmented as below:
By Type
- Diabetic
- Chemotherapy
- Others
By Therapy
- Pharmacological therapies
- Non pharmacological therapies
By Diagnostic Methods
- Blood test
- Biopsy
- Imaging
By End-user
- Hospitals and clinics
- Retail pharmacy
- Online pharmacy
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the strong drug pipeline as one of the prime reasons driving the peripheral neuropathy treatment market growth during the next few years. Also, technological advances with new formulations of drugs and increase in research and development associated with peripheral neuropathy treatment will lead to sizable demand in the market.
The report on the peripheral neuropathy treatment market covers the following areas:
- Peripheral Neuropathy Treatment Market sizing
- Peripheral Neuropathy Treatment Market forecast
- Peripheral Neuropathy Treatment Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading peripheral neuropathy treatment market vendors that include Apotex Inc., ASSERTIO HOLDINGS INC., AstraZeneca Plc, Cadila Pharmaceuticals Ltd., Cipla Inc., Daiichi Sankyo Co. Ltd., Dr Reddys Laboratories Ltd., Eli Lilly and Co., Endo International Plc, Grunenthal GmbH, Hikma Pharmaceuticals Plc, Johnson and Johnson Services Inc., Lupin Ltd., Novartis AG, Pfizer Inc., SHIONOGI Co. Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., UCB SA, and Viatris Inc.. Also, the peripheral neuropathy treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Therapy
- Executive Summary - Chart on Market Segmentation by Diagnostic Methods
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
- 3.3 Value chain analysis
- Value chain analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5.1 Global Peripheral Neuropathy Treatment Market 2019 - 2023
- Historic Market Size - Data Table on Global Peripheral Neuropathy Treatment Market 2019 - 2023 ($ million)
- 5.2 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ million)
- 5.3 Therapy segment analysis 2019 - 2023
- Historic Market Size - Therapy Segment 2019 - 2023 ($ million)
- 5.4 Diagnostic Methods segment analysis 2019 - 2023
- Historic Market Size - Diagnostic Methods Segment 2019 - 2023 ($ million)
- 5.5 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
- 5.6 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.7 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 The AI impact on Global Peripheral Neuropathy Treatment Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Type
- 8.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
- 8.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 8.3 Diabetic - Market size and forecast 2024-2029
- Chart on Diabetic - Market size and forecast 2024-2029 ($ million)
- Data Table on Diabetic - Market size and forecast 2024-2029 ($ million)
- Chart on Diabetic - Year-over-year growth 2024-2029 (%)
- Data Table on Diabetic - Year-over-year growth 2024-2029 (%)
- 8.4 Chemotherapy - Market size and forecast 2024-2029
- Chart on Chemotherapy - Market size and forecast 2024-2029 ($ million)
- Data Table on Chemotherapy - Market size and forecast 2024-2029 ($ million)
- Chart on Chemotherapy - Year-over-year growth 2024-2029 (%)
- Data Table on Chemotherapy - Year-over-year growth 2024-2029 (%)
- 8.5 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 8.6 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Therapy
- 9.1 Market segments
- Chart on Therapy - Market share 2024-2029 (%)
- Data Table on Therapy - Market share 2024-2029 (%)
- 9.2 Comparison by Therapy
- Chart on Comparison by Therapy
- Data Table on Comparison by Therapy
- 9.3 Pharmacological therapies - Market size and forecast 2024-2029
- Chart on Pharmacological therapies - Market size and forecast 2024-2029 ($ million)
- Data Table on Pharmacological therapies - Market size and forecast 2024-2029 ($ million)
- Chart on Pharmacological therapies - Year-over-year growth 2024-2029 (%)
- Data Table on Pharmacological therapies - Year-over-year growth 2024-2029 (%)
- 9.4 Non pharmacological therapies - Market size and forecast 2024-2029
- Chart on Non pharmacological therapies - Market size and forecast 2024-2029 ($ million)
- Data Table on Non pharmacological therapies - Market size and forecast 2024-2029 ($ million)
- Chart on Non pharmacological therapies - Year-over-year growth 2024-2029 (%)
- Data Table on Non pharmacological therapies - Year-over-year growth 2024-2029 (%)
- 9.5 Market opportunity by Therapy
- Market opportunity by Therapy ($ million)
- Data Table on Market opportunity by Therapy ($ million)
10 Market Segmentation by Diagnostic Methods
- 10.1 Market segments
- Chart on Diagnostic Methods - Market share 2024-2029 (%)
- Data Table on Diagnostic Methods - Market share 2024-2029 (%)
- 10.2 Comparison by Diagnostic Methods
- Chart on Comparison by Diagnostic Methods
- Data Table on Comparison by Diagnostic Methods
- 10.3 Blood test - Market size and forecast 2024-2029
- Chart on Blood test - Market size and forecast 2024-2029 ($ million)
- Data Table on Blood test - Market size and forecast 2024-2029 ($ million)
- Chart on Blood test - Year-over-year growth 2024-2029 (%)
- Data Table on Blood test - Year-over-year growth 2024-2029 (%)
- 10.4 Biopsy - Market size and forecast 2024-2029
- Chart on Biopsy - Market size and forecast 2024-2029 ($ million)
- Data Table on Biopsy - Market size and forecast 2024-2029 ($ million)
- Chart on Biopsy - Year-over-year growth 2024-2029 (%)
- Data Table on Biopsy - Year-over-year growth 2024-2029 (%)
- 10.5 Imaging - Market size and forecast 2024-2029
- Chart on Imaging - Market size and forecast 2024-2029 ($ million)
- Data Table on Imaging - Market size and forecast 2024-2029 ($ million)
- Chart on Imaging - Year-over-year growth 2024-2029 (%)
- Data Table on Imaging - Year-over-year growth 2024-2029 (%)
- 10.6 Market opportunity by Diagnostic Methods
- Market opportunity by Diagnostic Methods ($ million)
- Data Table on Market opportunity by Diagnostic Methods ($ million)
11 Market Segmentation by End-user
- 11.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
- 11.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 11.3 Hospitals and clinics - Market size and forecast 2024-2029
- Chart on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
- Chart on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
- 11.4 Retail pharmacy - Market size and forecast 2024-2029
- Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
- Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
- Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
- Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
- 11.5 Online pharmacy - Market size and forecast 2024-2029
- Chart on Online pharmacy - Market size and forecast 2024-2029 ($ million)
- Data Table on Online pharmacy - Market size and forecast 2024-2029 ($ million)
- Chart on Online pharmacy - Year-over-year growth 2024-2029 (%)
- Data Table on Online pharmacy - Year-over-year growth 2024-2029 (%)
- 11.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
12 Customer Landscape
- 12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
- 13.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
- 13.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 13.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- 13.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- 13.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- 13.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- 13.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 13.8 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 13.9 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 13.10 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 13.11 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 13.12 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 13.13 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- 13.14 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 13.15 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- 13.16 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 13.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
14 Drivers, Challenges, and Opportunity/Restraints
- 14.1 Market drivers
- 14.2 Market challenges
- 14.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 14.4 Market opportunities/restraints
15 Competitive Landscape
- 15.1 Overview
- 15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 15.3 Landscape disruption
- Overview on factors of disruption
- 15.4 Industry risks
- Impact of key risks on business
16 Competitive Analysis
- 16.1 Companies profiled
- Companies covered
- 16.2 Company ranking index
- Company ranking index
- 16.3 Market positioning of companies
- Matrix on companies position and classification
- 16.4 Apotex Inc.
- Apotex Inc. - Overview
- Apotex Inc. - Product / Service
- Apotex Inc. - Key news
- Apotex Inc. - Key offerings
- SWOT
- 16.5 ASSERTIO HOLDINGS INC.
- ASSERTIO HOLDINGS INC. - Overview
- ASSERTIO HOLDINGS INC. - Product / Service
- ASSERTIO HOLDINGS INC. - Key offerings
- SWOT
- 16.6 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT
- 16.7 Cadila Pharmaceuticals Ltd.
- Cadila Pharmaceuticals Ltd. - Overview
- Cadila Pharmaceuticals Ltd. - Product / Service
- Cadila Pharmaceuticals Ltd. - Key offerings
- SWOT
- 16.8 Cipla Inc.
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
- SWOT
- 16.9 Daiichi Sankyo Co. Ltd.
- Daiichi Sankyo Co. Ltd. - Overview
- Daiichi Sankyo Co. Ltd. - Product / Service
- Daiichi Sankyo Co. Ltd. - Key offerings
- SWOT
- 16.10 Dr Reddys Laboratories Ltd.
- Dr Reddys Laboratories Ltd. - Overview
- Dr Reddys Laboratories Ltd. - Business segments
- Dr Reddys Laboratories Ltd. - Key news
- Dr Reddys Laboratories Ltd. - Key offerings
- Dr Reddys Laboratories Ltd. - Segment focus
- SWOT
- 16.11 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings
- SWOT
- 16.12 Endo International Plc
- Endo International Plc - Overview
- Endo International Plc - Business segments
- Endo International Plc - Key news
- Endo International Plc - Key offerings
- Endo International Plc - Segment focus
- SWOT
- 16.13 Hikma Pharmaceuticals Plc
- Hikma Pharmaceuticals Plc - Overview
- Hikma Pharmaceuticals Plc - Business segments
- Hikma Pharmaceuticals Plc - Key news
- Hikma Pharmaceuticals Plc - Key offerings
- Hikma Pharmaceuticals Plc - Segment focus
- SWOT
- 16.14 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- SWOT
- 16.15 Lupin Ltd.
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
- 16.16 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- 16.17 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
- 16.18 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT
17 Appendix
- 17.1 Scope of the report
- 17.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 17.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 17.4 Research methodology
- Research methodology
- 17.5 Data procurement
- Information sources
- 17.6 Data validation
- Data validation
- 17.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 17.8 Data synthesis
- Data synthesis
- 17.9 360 degree market analysis
- 360 degree market analysis
- 17.10 List of abbreviations
- List of abbreviations
